2-METHYL-6-(TRIFLUOROMETHOXY)-1H-INDOLE, 95.0%, 1g

n-(6-Amino-1-butyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-n-benzyl-2-chloroacetamide, 98%, 250mg

(S)-4-(Benzo[b]thiophen-3-yl)-3-((tert-butoxycarbonyl)amino)butanoic acid, 97%, 1g

1-ETHYNYLPYRENE, 97.0%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-((1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl)amino)propanoic acid, 97%, 5g

monoclonal de ratón anti-queratina K17, Ks17.E3, 0,2 ml

Chloroquine>98.0%(HPLC)(T)250mg

6-chloro-1,4-dihydropyridazin-4-one, 98%, 1g

2,2,4,4,6,8,8-Heptamethylnonane>97.0%(GC)500mL

2,5-dimethyl-1H-pyrrole-3-carbaldehyde, 95.0%, 10g

(1r)-1-(4-Bromothiophen-2-yl)ethan-1-amine hydrochloride, 98%, 1g

2,2-Dimethyl-2H-chromen-5-ol, 98%, 100mg

2-Bromo-5-fluoro-4-methylbenzaldehyde, 95.0%, 5g